Related Experiment Video
Updated: May 7, 2026

06:03
Integrating Augmented Reality Tools in Breast Cancer Related Lymphedema Prognostication and Diagnosis
Published on: February 6, 2020
6.1K
Risk Stratification for Breast Cancer Screening: AJR Expert Panel Narrative Review
Cody Schopf1, Susan M Domchek2, Jeffrey A Tice3
1University of Washington, Department of Radiology and Fred Hutchinson Cancer Center, Seattle, USA.
AJR. American Journal of Roentgenology
|May 6, 2026
Summary
Personalized breast cancer screening, guided by risk prediction tools, can optimize benefits and reduce harms. This review examines current models, guidelines, and future directions for risk-stratified screening strategies.
Area of Science:
- Radiology and Oncologic Imaging
- Medical Informatics
- Public Health
Background:
- Early breast cancer detection significantly reduces mortality.
- Screening effectiveness is enhanced by aligning strategies with individual cancer risk profiles.
- Risk prediction tools aid in assessing patient-specific cancer risks.
Purpose of the Study:
- To review breast cancer risk stratification methods and prediction models.
- To analyze current societal guidelines on risk assessment tool utilization.
- To propose a practical framework for integrating risk assessment into clinical practice.
Main Methods:
- Narrative review of breast cancer risk stratification.
- Overview of commonly used clinical risk prediction models.
- Analysis of existing professional society guidelines.
Main Results:
- Variability exists in professional society recommendations for risk assessment.
- Uncertainty persists regarding standardized risk assessment approaches and tool implementation.
- Deep learning models show potential for future risk stratification.
Conclusions:
- Aligning screening with individual risk profiles improves benefit-harm balance.
- Standardized risk assessment and clear guidelines are needed for effective implementation.
- Future research, including deep learning, can refine breast cancer screening strategies.
More Related Videos
Related Concept Videos
Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
631
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
631
Relative Risk
2.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Hazard Ratio
786
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
786

